news.today
Hello · Register today | LoginHello · My Account[—] [33]
Business

Biotech firm T-Cypher Bio moves to new Oxfordshire facility

Summarised from 2 outlets · Updated 15 Nov, 06:01 · Archive

T-Cypher Bio has relocated its headquarters to Barton House at Abingdon Science Park in Oxfordshire.

T-Cypher Bio, a biotechnology company developing T cell receptor-based therapeutics, has relocated its headquarters to Barton House at Abingdon Science Park in Oxfordshire. The purpose-built laboratory space, delivered by Kadans Science Partner, will house the company's work on novel immune engager therapies targeting solid tumours and autoimmune disease. T-cell receptor-based therapies use the body's immune system to recognise and attack harmful cells, such as cancer cells.

Chief executive Sarah Leonard said the move allowed expansion of the company's tissue culture space, which was critical to the in-vitro work needed for clinical development studies. She praised Kadans's involvement in the design process from the start, which ensured the new space met the company's requirements and enabled a seamless transition between sites with minimal disruption to research activities.

Leonard also commended the quality and speed of the facility's delivery. She described the relocation as an exciting milestone for the company as it advances its pipeline toward clinical development. T-Cypher's integrated discovery platform, T-C Alpha, combines computational and laboratory systems to identify high copy number targets and develop next-generation therapeutics.

Biotech firm T-Cypher Bio moves to new Oxfordshire facility
Image: Oxfordshire Guardian

Comments (0)

How it is being reported

In this story: T-Cypher Bio · Abingdon Science Park · Oxfordshire · Kadans Science Partner · Sarah Leonard

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log